Reply to ‘Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2’ by Solimani et alArticle Published on 2022-10-012022-11-15 Journal: Journal of the European Academy of Dermatology and [Category] COVID19(2023년), SARS, 진단, [키워드] BNT162b2 development Reply SARS-CoV-2 vaccination [DOI] 10.1111/jdv.18302 PMC 바로가기
Reply to Chambers, P. Comment on “Huțanu et al. Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients’ Outcomes-A Single-Center Experience and a Brief Review of the Literature. Nutrients 2022, 14, 1998”Chambers에 대한 답변, P. "Huțanu et al. COVID-19 환자의 저혈청 비타민 D는 염증 마커 및 환자의 결과와 관련이 없습니다-단일 센터 경험 및 문헌에 대한 간략한 검토. 영양소 2022, 14 , 1998"Review Published on 2022-08-182022-09-11 Journal: Nutrients [Category] 바이오마커, [키워드] chamber Comment COVID-19 experience literature nutrient Reply review Vitamin D [DOI] 10.3390/nu14163389 PMC 바로가기 [Article Type] Review
Reply to the Letter to the Editor: Takotsubo syndrome in the setting of COVID-19: Pathogenetic and diagnostic implicationsCorrespondence Published on 2022-08-012022-10-05 Journal: Revista portuguesa de cardiologia [Category] 진단, [키워드] diagnostic implication Reply syndrome [DOI] 10.1016/j.repc.2022.08.004 [Article Type] Correspondence
Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic답장: SARS-Cov-2 팬데믹 기간 및 이후 SLE 환자의 표지자로서 혈청 S100B의 유용성Comment Published on 2022-07-012022-09-11 Journal: Archives of medical research [Category] COVID19(2023년), MERS, SARS, 바이오마커, [키워드] Reply S100B SLE [DOI] 10.1016/j.arcmed.2022.05.005 PMC 바로가기 [Article Type] Comment
Reply to correspondence: Basophil reactivity to BNT162b2 in COVID-19 convalescence서신에 회신: COVID-19 회복기에 BNT162b2에 대한 호염기구 반응성Comment Published on 2022-07-012022-09-12 Journal: Allergy [Category] MERS, 진단, [키워드] basophil BNT162b2 COVID-19 reactivity Reply [DOI] 10.1111/all.15208 PMC 바로가기 [Article Type] Comment
Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”회신: "리툭시맙을 투여받는 IMID 환자의 코로나19 예방접종: 개인화 요법이 공식화되어야 합니다"Comment Published on 2022-07-012022-09-12 Journal: Journal of the American Academy of Dermatology [Category] MERS, 진단, [키워드] Patient receiving regimen Reply vaccination [DOI] 10.1016/j.jaad.2022.03.042 PMC 바로가기 [Article Type] Comment
Reply to Carlos G. Wambier and Gerard J. Nau’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients: Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 PatientsCorrespondence Published on 2022-06-012022-10-05 Journal: European urology [Category] 임상, [키워드] antiandrogen COVID-19 Effect enzalutamide evidence of Magnus Phase 2 Reply Still [DOI] 10.1016/j.eururo.2022.02.016 [Article Type] Correspondence
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 Research Published on 2022-05-272022-10-05 Journal: Nature Immunology [Category] 유전자 메커니즘, 임상, [키워드] COVID-19 Critical genetic determinant genetics Reply thromboembolic complication [DOI] 10.1038/s41590-022-01228-9 [Article Type] Research
Authors Reply to: Research Using Social Media to Recruit Research Participants Should Proceed With Caution. Comment on “Telemanagement of Home-Isolated COVID-19 Patients Using Oxygen Therapy With Noninvasive Positive Pressure Ventilation and Physical Therapy Techniques: Randomized Clinical Trial”Randomized Controlled Trial Published on 2022-05-022022-10-05 Journal: Journal of Medical Internet Research [Category] 임상, [키워드] Abstract airway BiPAP caution clinical Comment COVID-19 noninvasive noninvasive positive airway pressure osteopathic medicine oxygen Oxygen therapy participant physical Physical therapy positive pressure Reply SARS-CoV-2 telemanagement Telemedicine teletherapy [DOI] 10.2196/37413 PMC 바로가기 [Article Type] Randomized Controlled Trial
Reply to letter to the editor by Lippi and Plebani: « The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization » (THEIJID-D-22-00085)Lippi와 Plebani가 편집자에게 보낸 편지에 대한 답장: « 항-SARS-CoV-2 항체의 존재가 반드시 효율적인 중화를 반영하는 것은 아닙니다. » (THEIJID-D-22-00085)Comment Published on 2022-04-012022-09-12 Journal: International Journal of Infectious Diseases [Category] MERS, 진단, [키워드] anti-SARS-CoV-2 antibody neutralization Reply [DOI] 10.1016/j.ijid.2022.01.059 PMC 바로가기 [Article Type] Comment